Volume 32, Issue 10 (January 2022)                   Studies in Medical Sciences 2022, 32(10): 793-798 | Back to browse issues page

Ethics code: IR.TBZMED.REC.1398.420


XML Persian Abstract Print


Fellowship Assistant, Tabriz University of Medical Sciences, Tabriz, Iran (Corresponding Author) , yalda.md85@gmail.com
Abstract:   (1607 Views)
Background & Aims: Decompressive Craniectomy (DC) is recommended for patients with extensive cerebral infarction. At this study, we aimed to assess the mortality and 3-month outcome of these patients who are not going under DC.
Material & Methods: In this prospective descriptive study, all patients referred to Imam Reza Hospital in Urmia, Iran, from 2017-2019 with extensive ischemic stroke with refractory medical edema of the brain who did not undergo surgery were included. Patient’s demographic and other brain stroke-related data were recorded. Patients were evaluated for the improvement of brain stroke symptoms based on the comparison of National Institutes of Health Stroke Scale (NIHSS) criteria at the time of hospitalization with discharge time and also for the degree of disability and mortality at three months follow-up according to mRS criteria. P values less than 0.05 were considered statistically significant.
Results: A total of 28 patients were enrolled in the study. Median age was 76 years. NIHSS score was 21 at admission and 18 at discharge (p<0.05). Of all 28 patient, 22 (78.6%) died during hospital admission and 24 (85.7%) died up to 3 month follow up. None of the 4 survived patients had a good and independent outcome along the 3-month follow-up (MRS<3).
Conclusion: Results of this study showed that in patients with extensive cerebral infarction with edema resistant to medical treatment, fail to perform decompressive craniectomy is associated with a very high mortality rate and poor prognosis.
Full-Text [PDF 489 kb]   (637 Downloads)    
Type of Study: Research | Subject: داخلی مغز و اعصاب

References
1. Adams Jr HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh 3rd EE.Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; Jan;24(1):35-41. [DOI:10.1161/01.STR.24.1.35] [PMID]
2. Wijdicks EF, Sheth KN, Carter BS, Greer DM, Kasner SE, Kimberly WT, Schwab S, Smith EE, Tamargo RJ, Wintermark M. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014 Apr;45(4):1222-38. [DOI:10.1161/01.str.0000441965.15164.d6] [PMID]
3. Cushing H. The establishment of cerebral hernia as a decompressive measure for inaccessible brain tumors: with the description of intermuscular methods of making the bone defect in temporal and occipital regions. Surg Gynecol Obstet 1905;1:297-314. [URL]
4. Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner HH, Jansen O, Hacke W. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 1998 Sep;29(9):1888-93. [DOI:10.1161/01.STR.29.9.1888] [PMID]
5. Intiso D, Lombardi T, Grimaldi G, Iarossi A, Tolfa M, Russo M, Di Rienzo F. Long-term outcome and health status in decompressive craniectomized patients with intractable intracranial pressure after severe brain injury. Brain Injury 2011 Apr 1;25(4):379-86. [DOI:10.3109/02699052.2011.558046] [PMID]
6. Molina CA, Selim MH. Decompressive hemicraniectomy in elderly patients with malignant hemispheric infarction: open questions remain beyond DESTINY. Stroke 2011 Mar;42(3):847-8. [DOI:10.1161/STROKEAHA.110.603613] [PMID]
7. Tjahjadi M, Heinen C, König R, Rickels E, Wirtz CR, Woischneck D, Kapapa T. Health-related quality of life after spontaneous subarachnoid hemorrhage measured in a recent patient population. World neurosurgery. 2013 Feb 1;79(2):296-307. [DOI:10.1016/j.wneu.2012.10.009] [PMID]
8. Adams Jr HP, Biller J. Classification of subtypes of ischemic stroke: history of the trial of org 10 172 in acute stroke treatment classification. Stroke 2015 May;46(5):e114-7. [DOI:10.1161/STROKEAHA.114.007773] [PMCID]
9. Vahedi K, Vicaut E, Mateo J, Kurtz A, Orabi M, Guichard JP, Boutron C, Couvreur G, Rouanet F, Touzé E, Guillon B. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke 2007 Sep 1;38(9):2506-17. [DOI:10.1161/STROKEAHA.107.485235] [PMID]
10. Jüttler E, Schwab S, Schmiedek P, Unterberg A, Hennerici M, Woitzik J, Witte S, Jenetzky E, Hacke W. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY) a randomized, controlled trial. Stroke 2007 Sep 1;38(9):2518-25. [DOI:10.1161/STROKEAHA.107.485649] [PMID]
11. Geurts M, van der Worp HB, Kappelle LJ, Amelink GJ, Algra A, Hofmeijer J. Surgical decompression for space-occupying cerebral infarction: outcomes at 3 years in the randomized HAMLET trial. Stroke 2013 Sep;44(9):2506-8. [DOI:10.1161/STROKEAHA.113.002014] [PMID]
12. Zhang J, Yang XA, Zhang Y, Wei JY, Yang F, Gao H, Jiao WW, Sun XL, Gao Q, Jiang W. Oral anticoagulant use in atrial fibrillation-associated ischemic stroke: a retrospective, multicenter survey in Northwestern China. J Stroke Cerebrovasc Dis 2017 Jan 1;26(1):125-31. [DOI:10.1016/j.jstrokecerebrovasdis.2016.08.042] [PMID]
13. Back L, Nagaraja V, Kapur A, Eslick GD. Role of decompressive hemicraniectomy in extensive middle cerebral artery strokes: a meta‐analysis of randomised trials. Intern Med J 2015 Jul;45(7):711-7. [DOI:10.1111/imj.12724] [PMID]
14. Torbey MT, Bösel J, Rhoney DH, Rincon F, Staykov D, Amar AP, Varelas PN, Jüttler E, Olson D, Huttner HB, Zweckberger K. Evidence-based guidelines for the management of large hemispheric infarction. Neurocrit Care 2015 Feb;22(1):146-64. [DOI:10.1007/s12028-014-0085-6] [PMID]
15. Reinink H, Jüttler E, Hacke W, Hofmeijer J, Vicaut E, Vahedi K, Slezins J, Su Y, Fan L, Kumral E, Greving JP. Surgical decompression for space-occupying hemispheric infarction: a systematic review and individual patient meta-analysis of randomized clinical trials. JAMA Neurol 2021 Feb 1;78(2):208-16. [DOI:10.1001/jamaneurol.2020.3745] [PMID] [PMCID]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.